A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

Abstract

Overall, there was no significant difference in the rates of death and major cardiovascular events between patients undergoing prompt revascularization and those undergoing medical therapy or between strategies of insulin sensitization and insulin provision. (ClinicalTrials.gov number, NCT00006305.)